Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Factors affecting therapeutic placebo response rates in patients with irritable bowel syndrome

Nature Clinical Practice Gastroenterology & Hepatology volume 2, pages 354–355 (2005)Cite this article

boxed-textPitz M et al. (2005) Defining the predictors of the placebo response in irritable bowel syndrome. Clin Gastroenterol Hepatol 3: 237–247

It might be more effective to maximize the efficacy of IBS treatments by improving patient compliance to treatment than by strengthening placebo responses

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ilnyckyj A et al. (1997) Quantification of the placebo response in ulcerative colitis. Gastroenterology 112: 1854–1858

    Article  CAS  Google Scholar 

  2. Enck P and Klosterhalfen S (2005) The placebo response in functional bowel disorders: perspectives and putative mechanisms. Neurogastroenterol Motil 17: 325–331

    Article  CAS  Google Scholar 

  3. Chey WD et al. (2004) Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 99: 2185–2203

    Article  Google Scholar 

  4. Patel SM et al. (2005) The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 17: 332–340

    Article  CAS  Google Scholar 

  5. Moayyedi P (2004) Meta-analysis: can we mix apples with oranges? Am J Gastroenterol 99: 2297–2301

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Katy Cherry, Assistant Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor and Director of Research at University Hospitals Tübingen, Tübingen, Germany

    Paul Enck

  2. Psychologist at University Hospitals Düsseldorf, Düsseldorf, Germany

    Sibylle Klosterhalfen

  3. Gastroenterologist at Evangelisches Krankenhaus Köln-Kalk, Köln, Germany

    Wolfgang Kruis

Authors
  1. Paul Enck
    View author publications

    Search author on:PubMed Google Scholar

  2. Sibylle Klosterhalfen
    View author publications

    Search author on:PubMed Google Scholar

  3. Wolfgang Kruis
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Paul Enck.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Enck, P., Klosterhalfen, S. & Kruis, W. Factors affecting therapeutic placebo response rates in patients with irritable bowel syndrome. Nat Rev Gastroenterol Hepatol 2, 354–355 (2005). https://doi.org/10.1038/ncpgasthep0237

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpgasthep0237

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing